Finance

Grab Bets on AI, New Services to Triple Profit by 2028

AC
Alex Chen
Tech Journalist & Product Reviewer
Singapore’s Grab bets on AI, new services to triple profit by 2028
Image source: Investing.com

Singapore's Grab Aims for Tripled Profit by 2028

Singapore's ride-hailing giant Grab is betting big on artificial intelligence (AI) and new services to triple its profit by 2028. The company's ambitious plan was revealed in a recent report by Investing.com [2].

According to the report, Grab's AI-powered services are expected to play a crucial role in driving the company's growth. The company has been investing heavily in AI research and development, with a focus on improving its ride-hailing and food delivery services.

Grab's CEO has stated that the company is committed to using AI to enhance customer experience and improve operational efficiency. The company's AI-powered services are expected to help it reduce costs and increase revenue.

AI-Powered Services to Drive Growth

Grab's AI-powered services are expected to drive growth in several areas, including:

  • Improved ride-hailing services: Grab's AI-powered ride-hailing services are expected to reduce wait times and improve the overall customer experience.
  • Enhanced food delivery services: Grab's AI-powered food delivery services are expected to improve delivery times and increase customer satisfaction.
  • Increased revenue: Grab's AI-powered services are expected to increase revenue through improved operational efficiency and reduced costs.

Tripled Profit by 2028

Grab's ambitious plan to triple its profit by 2028 is a significant milestone for the company. The company's revenue has been growing steadily in recent years, and its AI-powered services are expected to play a crucial role in driving this growth.

Conclusion

Grab's bet on AI and new services is a significant move that is expected to drive growth and increase revenue. The company's commitment to using AI to enhance customer experience and improve operational efficiency is a key factor in its success.

Sources

[1] GSK’s linerixibat wins priority review in China for rare liver disease
[2] Singapore’s Grab bets on AI, new services to triple profit by 2028